Skip to main content
Ruth Karron, MD, Pediatric Infectious Disease, Baltimore, MD

RuthA.KarronMD

Pediatric Infectious Disease • Baltimore, MD

Joint of Pediatrics, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Karron is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Karron's full profile

Already have an account?

  • Office

    1800 Orleans St.
    Sheikh Zayed Tower
    Baltimore, MD 21287
    Phone+1 410-614-3917

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Infectious Disease, 1987 - 1988
  • National Capital Consortium
    National Capital ConsortiumResidency, Pediatrics, 1985 - 1987
  • Children's National Hospital
    Children's National HospitalResidency, Pediatrics, 1982 - 1985
  • New York University School of Medicine
    New York University School of MedicineClass of 1982

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 1989 - 2026
  • Pediatrics
    American Board of Pediatrics Pediatrics

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Informing Randomized Clinical Trials of Respiratory Syncytial Virus Vaccination During Pregnancy to Prevent Recurrent Childhood Wheezing: A Sample Size Analysis  
    Tina V Hartert, Niranjan Bhat, Ruth A Karron, Justin R Ortiz, ScienceDirect

Authored Content

  • An ‘Indefensible’ Decision: Not Vaccinating Pregnant and Lactating Women in an Ebola OutbreakAugust 2018

Press Mentions

  • We’ll Soon Have Tools To Protect Infants Against RSV. Can We Put Them To Good Use?
    We’ll Soon Have Tools To Protect Infants Against RSV. Can We Put Them To Good Use?May 24th, 2023
  • FDA Approves First Vaccine for RSV, a Moment Six Decades in the Making
    FDA Approves First Vaccine for RSV, a Moment Six Decades in the MakingMay 3rd, 2023
  • FDA Approves World’s First RSV Vaccine for Adults 60 and Older
    FDA Approves World’s First RSV Vaccine for Adults 60 and OlderMay 3rd, 2023
  • Join now to see all

External Links

Dr. Ruth Karron, Dr. Ruth Karron, MD, Dr. R Karron, Dr. Ruth A. Karron